MedulloblastomaSymptoms, Doctors, Treatments, Advances & More
Medulloblastoma Overview
Learn About Medulloblastoma
View Main Condition: Brain Tumor
SJCH Pediatric Hematology & Oncology
Don Eslin is a Hematologist and an Oncologist practicing medicine in Tampa, Florida. Dr. Eslin is rated as a Distinguished provider by MediFind in the treatment of Medulloblastoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Embryonal Tumor with Multilayered Rosettes, Neuroblastoma, Medulloblastoma, Gliomatosis Cerebri, and Bone Marrow Aspiration. Dr. Eslin is board certified in AB Pediatrics (Pediatric Hematology-Oncology) and AB Pediatrics - Pediatrics. Dr. Eslin is currently accepting new patients.
St. Jude Children's Research Hospital
Amar Gajjar is a Hematologist and an Oncologist practicing medicine in Memphis, Tennessee. Dr. Gajjar is rated as an Elite provider by MediFind in the treatment of Medulloblastoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Medulloblastoma, Posterior Fossa Tumor, Brain Tumor, Embryonal Tumor with Multilayered Rosettes, and Posterior Fossa Decompression. Dr. Gajjar is currently accepting new patients.
Andrey Korshunov practices practicing medicine in Heidelberg, Germany. Mr. Korshunov is rated as an Elite expert by MediFind in the treatment of Medulloblastoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Ependymoma, and Gliomatosis Cerebri.
Summary: This study is a clinical trial to determine the safety of inoculating G207 (an experimental virus therapy) into a recurrent or refractory cerebellar brain tumor. The safety of combining G207 with a single low dose of radiation, designed to enhance virus replication, tumor cell killing, and an anti-tumor immune response, will also be tested. Funding Source- FDA OOPD
Summary: The purpose of this research study is to test the safety and effectiveness of a cell therapy at different doses for children and young adults with recurrent or progressive brain tumors. Recurrent/recurred means a tumor that has gone away and then came back. This cell therapy is called B7- H3.CD28Z.CART, referred to as B7-H3 CAR T cells. B7-H3 is a protein that is over-expressed on many tumor cells...

Keep Punching supports patients, healthcare providers, and researchers in their fight to prevent and eradicate brain cancer and minimize treatment-related side effects that may adversely impact function and comfort.
